Clik here to view.
New Drug Monograph for Pristiq
The FDA has approved Pristiq (desvenlafaxine), the major active metabolite of venlafaxine, for the treatment of major depressive disorder in adults. Learn more at www.epocrates.com
View ArticleClik here to view.
Adult Indication and Additional Capsule Sizes for Vyvanse
The FDA has approved Vyvanse (lisdexamfetamine) for the treatment of ADHD in adults. It is also now available in 20 mg, 40 mg, and 60 mg capsule strengths. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Ropinirole
The FDA has approved first-time generic formulations for ropinirole. Ropinirole is equivalent to Requip, which is indicated for the treatment of moderate to severe primary restless legs syndrome and...
View ArticleClik here to view.
New Dosage Form for Paroxetine
The FDA has approved a first-time generic extended-release form of paroxetine. Paroxetine ER is equivalent to Paxil CR, which is indicated for the treatment of major depressive disorder, panic...
View ArticleClik here to view.
Additional Indication for Amitiza
The FDA has approved Amitiza (lubiprostone) to treat irritable bowel syndrome with constipation in women, making it the first drug to win approval for this condition. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Relistor
The FDA has approved Relistor (methylnaltrexone) to treat opioid-induced constipation. Learn more at www.epocrates.com
View ArticleClik here to view.
New Black Box Warning for Regranex
The prescribing information for Regranex (becaplermin topical) now includes a black box warning. An increased rate of mortality secondary to malignancy was observed in patients treated with 3 or more...
View ArticleClik here to view.
Expanded Indication for Advair Diskus
The FDA has approved Advair Diskus (fluticasone/salmeterol inhaled) for maintenance therapy of COPD, which now includes the treatment of emphysema as well as chronic bronchitis. Learn more at...
View ArticleClik here to view.
New Black Box Warning for Conventional Antipsychotics
The FDA has reviewed data indicating that conventional antipsychotics are also associated with an increased risk of mortality in elderly patients treated for dementia-related psychosis. In 2005, the...
View ArticleClik here to view.
New Monthly Dosing for Actonel
The FDA has approved once-monthly dosing of Actonel (risedronate) for the prevention and treatment of postmenopausal osteoporosis. Learn more at www.epocrates.com
View ArticleClik here to view.
New Monograph for Risperidone
The FDA has approved first-time generic formulations for risperidone. Risperidone is equivalent to Risperdal, which is indicated for the treatment of schizophrenia and the acute mania of bipolar...
View ArticleClik here to view.
New Monograph for zaleplon
First-time generic formulations for zaleplon are now available. Zaleplon is equivalent to Sonata, which is indicated for the short-term treatment of insomnia (sleep-onset type). Learn more at...
View ArticleClik here to view.
New Monograph for Kinrix
The FDA has approved Kinrix (diphtheria/tetanus toxoids and acellular pertussis/poliovirus, inactivated vaccine) for combination immunization in children 4-6 years old. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Pentacel
The FDA has approved Pentacel (diphtheria/tetanus toxoids and acellular pertussis/poliovirus, inactivated/Haemophilus b vaccine) for immunization against diphtheria, tetanus, pertussis, polio, and...
View ArticleClik here to view.
New Drug Monograph for Ocella
The FDA has approved Ocella (drospirenone/ethinyl estradiol), a branded generic for Yasmin, for oral contraception. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Alvesco
The FDA has approved Alvesco (ciclesonide inhaled), an inhaled corticosteroid for maintenance therapy of asthma in adults and adolescents 12 years and older. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Fusilev
The FDA has approved Fusilev (levoleucovorin), a folate analog indicated for rescue therapy after high-dose methotrexate. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Rotarix
The FDA has approved Rotarix (rotavirus vaccine, live oral), a vaccine for the prevention of rotavirus gastroenteritis in infants and children. Learn more at www.epocrates.com
View ArticleClik here to view.
New Drug Monograph for Primalev
Primalev (acetaminophen/oxycodone) was recently launched for the treatment of moderate to moderate-severe pain, and features a lower strength of acetaminophen compared to similar products. Learn more...
View ArticleClik here to view.
New Drug Monograph for Nplate
Nplate (romiplostim), a thrombopoietin receptor agonist, was recently launched for the treatment of chronic immune (idiopathic) thrombocytopenia purpura (ITP) in adult patients with an insufficient...
View Article
